⌘K

Home/Filings/4/0001214659-20-002749

4//SEC Filing

Kendall Keith J 4

Accession 0001214659-20-002749

CIK 0001398733other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:46 PM ET

Size

5.4 KB

Accession

0001214659-20-002749

Insider Transaction Report

Form 4

Period: 2020-03-16

Aquestive Therapeutics, Inc.AQST

Kendall Keith J

DirectorCEO and President

Transactions

Award
Non-Qualified Stock Option (right to buy)
2020-03-16+225,000→ 225,000 total
Exercise: $1.54Exp: 2030-03-16→ Common Stock (225,000 underlying)

Footnotes (1)

[F1]The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.

Documents

1 file

4
marketforms-48348.xmlPrimary
PRIMARY DOCUMENT

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1

filerCIK 0001406834

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 4:46 PM ET
Size: 5.4 KB

View on SEC.gov